Skip to content
Subscriber Only

Valeant-Style Price Hikes Targeted for Review by Drug Plan

  • Express Scripts aims to `act within weeks, instead of months'
  • Program will quickly shift patients to less-expensive products
Updated on

Express Scripts Holding Co. said it’s starting a new program designed to respond rapidly to price spikes on old drugs, making it easier to steer patients to cheaper alternatives when a medicine unexpectedly soars in price.

The drug benefit manager’s new “market events” program, which will be optional for Express Scripts’ employer and health-insurer clients, is a response to big price increases on old treatments at specialty drugmakers like Valeant Pharmaceuticals International Inc. and Turing Pharmaceuticals AG.